Document is current
Any future updates will be listed below
-
Authors
Halbgebauer, Steffen
Klose, Veronika
Fazeli, Badrieh
Klassen, Paula
Alexudis, Christoforos
Nagel, Gabriele
Rosenbohm, Angela
Rothenbacher, Dietrich
Gomez de San Jose, Nerea
Witzel, Simon
Elmas, Zeynep
Wiesenfarth, Maximilian
Schuster, Joachim
Dorst, Johannes
Huss, Andre
Bachhuber, Franziska
Otto, Markus
Landwehrmeyer, G. Bernhard
Ludolph, Albert C.
Tumani, Hayrettin https://orcid.org/0000-0002-1647-6201
-
Funding
Funding for this research was provided by:
German Research Council (577 631)
German Federal Ministry of Education and Research (FTLDc 01GI1007A, moodmarker 01EW2008, Genfi-Prox 01ED2008A)
European Union (MIRIADE 860197)
Boehringer Ingelheim Ulm University BioCenter (D.5009)
Universitätsklinikum Ulm
- License Information
-
More Information
Article History
Received: 1 June 2025
Revised: 10 July 2025
Accepted: 13 July 2025
First Online: 25 July 2025
Declarations
:
: SH, VK, BF, PK, CA, GN, AR, DR, NG, SW, ZE, MW, JS, JD, AH, FB, MO, GBL, ACL report no competing interests. HT reports honoraria for acting as a consultant/speaker and/or for attending events sponsored by Alexion, Bayer, Biogen, Bristol-Myers Squibb, Celgene, Diamed, Fresenius, Fujirebio, GlaxoSmithKline, Horizon, Janssen-Cilag, Merck, Novartis, Roche, Sanofi-Genzyme, Siemens, Teva and Viatris. All conflicts are not relevant to the topic of the study.
: The examination was approved by the ethics committee of Ulm University (No. 11/10 and 20/10), the Medical Association of Baden-Wuerttemberg (No. B-F-2010-062), and the Medical Association of Bavaria (No. 7/11300) and conducted following the Declaration of Helsinki. All participants gave their written informed consent to participate in this study.
